XML 46 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Segment and Related Information (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Measures of Segment (Loss) Income
The measures of segment (loss) income for of our single reportable segment were as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
Net revenues from external customers(1)
$83,043 $85,782 $257,219 $245,758 
Significant segment expenses:
Personnel costs52,863 48,732 156,614 142,699 
Organizational and marketing costs11,267 10,271 39,983 33,106 
Inventory usage6,127 5,191 16,316 14,991 
Clinical studies and publication costs2,183 2,188 6,191 8,002 
Professional services2,524 2,559 8,398 8,103 
Other segment items8,580 14,572 51,543 30,202 
Segment (loss) income$(501)$2,269 $(21,826)$8,655 
(1)For information on disaggregation of segment revenue by type and information about payor concentration, see Note 3.
Schedule of Other Amounts Included in the Measure of Segment (Loss) Income
Other amounts included in the measure of segment (loss) income were as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
Interest income$2,833 $3,404 $8,876 $9,544 
Interest expense(24)(201)(62)(485)
Depreciation and amortization3,816 3,541 36,994 10,229 
Income tax expense (benefit)115 6,013 (4,974)5,024 
Stock-based compensation expense12,100 13,027 34,487 38,881 
Changes in fair value of equity securities3,561 — 3,321 —